HCPCS Code J2785: Injection, Regadenoson, 0.1 mg

J2785 documentation requirements

To properly report HCPCS code J2785, thorough documentation in the patient’s medical records is crucial. The following details must be included:

Medical necessity

Clearly state the medical necessity for using regadenoson, particularly why the patient was unable to perform a standard exercise stress test.

Administered dosage

Document the precise amount administered (study dose), typically reported per 0.1 mg unit. Include details about the single-dose vial used.

Route of administration

Include specifics regarding the intravenous administration of the regadenoson injection, such as time and site of injection.

Patient monitoring

Record vital signs such as heart rate and blood pressure before, during, and after the injection to confirm patient stability and response.

Diagnostic procedure performed

Clearly indicate the diagnostic imaging procedure or cardiac stress test performed alongside regadenoson administration.

J2785 billing requirements

Accurate billing of HCPCS code J2785 ensures correct reimbursement and compliance with payer regulations. Providers must follow these billing guidelines:

Correct unit reporting

Report one unit for every 0.1 mg of regadenoson administered to the patient.

Single-dose vial reporting

Clearly differentiate between the amount administered and any discarded drug when billing from single-dose vials.

Modifier usage

Use required modifiers such as JW (discarded drug) or JZ (no wastage) as applicable to the specific scenario.

Procedure linkage

Ensure J2785 is linked appropriately to the performed diagnostic procedure or cardiac imaging study.

Claim submission

Submit accurate claims promptly, ensuring completeness to avoid denials or delays in reimbursement.

J2785 applicable modifiers

Modifiers must accompany HCPCS code J2785 to indicate drug wastage status clearly. The required modifiers are:

1. JW – Drug amount discarded/not administered to any patient: Used when part of the drug from a single-dose vial is discarded. Bill administered and discarded amounts on separate claim lines.
2. JZ – Zero drug wasted: Confirms that the entire drug from the single-dose vial was administered to the patient, with no leftover drug discarded. This modifier became mandatory for full usage of single-dose vials effective July 1, 2023.

These modifiers are essential for compliance, especially with Medicare, as claims for J2785 without appropriate JW or JZ modifiers risk denial.

Other relevant codes

Providers may encounter other similar diagnostic radiopharmaceutical codes during practice. Some related HCPCS codes include:

• J0178: Injection, aflibercept, 1 mg – Used for treating ophthalmic conditions by inhibiting abnormal blood vessel growth.
• J0185: Injection, aprepitant – Administered to prevent chemotherapy-induced nausea and vomiting.
• J0153: Injection, adenosine, 1 mg – An alternative agent used during cardiac stress tests to evaluate coronary blood flow.
• J1245: Injection, dipyridamole, per 10 mg – Another vasodilator used during myocardial perfusion imaging when exercise stress testing is contraindicated.